Trigger Points
Conditions
Interventions
The sample will be randomly allocated to four groups:
(1) Dry Needling Group (GAS
n = 20): will be performed through the perforation of muscle tissue, with the use of a disposable needle and stainless steel with 0.25 × 30 mm.
(2) Ischemic Compression Group (GCI
n = 20): manual pressure will be applied on the trigger point for 90 seconds
(3) Shock Wave Therapy Group (GTOC
n = 20): high energy waves will be applied using the IBRAMED Thork Shock Wave® device. There will be 2000 shots at 20Hz, and an energy flow density of 60 mJ / mm².
(4) Control Group (GC
n = 20): the same equipment as the group Shock Wave Therapy will be used, but with the lowest energy provided by the equipment (5 shots at 1Hz, and an energy flow density of 60mJ)
The participant will
Sponsors
Universidade Estadual Paulista, Instituto de Biociências
Universidade Estadual Paulista
Eligibility
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Both genders; between 18 to 40 years old; presence of trigger points in the musculature; physically active; signed the statement of informed consent
Exclusion criteria
Exclusion criteria: Body Mass Index (BMI) above 30; have used analgesic, anti-inflammatory, anticoagulant, muscle relaxant or antipyretic medications up to 24 hours before; needle phobia; pregnant women; performed strenuous exercises or used stimulants 24 hours before; sensitivity or mental disorders diagnosed
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decreased of pain threshold produced by the trigger points, evaluated by the pressure pain threshold. Through the observation of a variation of at least 5% in the pre and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Decreased size or extinction of the trigger point, resulting in improved muscle muscle function, increased muscle strength, improved range of motion and muscle stretching, evaluated by imaging tests (thermography and ultrasound), muscle electromyography, isokinetic dynamometry and tests range of motion. Through the verification of a variation of at least 5% in the pre and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactCristiane ;Melissa Pedroni;Kuroda
;
Outcome results
None listed